SU
₹1,761.00
+3.50(+0.20%)
SUNPHARMA₹1,761.00+0.20%
Group Companies
Foreign Flows
sector level — not this stockHealthcare sector+₹2,114 Crnet foreign buying
2026-09-01 to 2026-09-15This is the flow into the whole Healthcare sector, not into SUNPHARMA. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.
Supply Chain
suppliers and customers in the graphMacro Sensitivity
rates, currency, commoditiesRevenue by Segment
Business Group
Geographic Exposure
revenue, imports, currencyScenario analysis
stated assumptions, shown workingsSUNPHARMA exposure summary
Sun Pharmaceutical Industries Limited reports a single business segment, Pharmaceuticals. Sun Pharmaceutical Industries Limited is a constituent of 12 indices, with its largest weights in NIFTY Pharma (19.51%), NIFTY Healthcare Index (16.94%), NIFTY India Manufacturing (3.92%). It is part of the Sun Pharma Group business group. 31 exchange-traded funds hold the stock.
| Index memberships | 12 |
|---|---|
| ETFs holding | 31 |
| Business group | Sun Pharma Group |